Neuroinflammation in Parkinson’s: Models, Mechanisms & Therapeutic Potential
Time: 8:30 am
day: Conference Day Two
Details:
- Immune System Abnormalities in Parkinson’s – Overview of the role of the NLRP3 inflammasome, T cell function, and immune cell trafficking between the gut and brain
- Preclinical Models for Neuroinflammation – Introduction to rodent and non-human primate models to study mechanisms and test novel therapeutics
- Translating Models to Drug Development – Some examples of how experimental systems can support the development of targeted neuroimmune therapies for Parkinson’s
- Evolving Perspectives on Disease Staging – Challenges of placing neuroinflammatory models within the broader framework of modern Parkinson’s disease staging
